Individualized follicle-stimulating hormone dosing and in vitro fertilization outcome in agonist downregulated cycles: a systematic review.

Theodora C van TilborgFrank J M BroekmansMadeleine DóllemanMarinus J C Eijkemans Ben-Willem J Mol Joop Stephanus Elisabeth LavenHelen L Torrance

Published in: Acta obstetricia et gynecologica Scandinavica (2017)

It is currently not possible to conclude whether individualized dosing leads to higher pregnancy or live birth rates compared with standard dosing, because evidence from well-designed studies that are adequately powered for one of these outcomes is lacking. So, large well-designed studies that evaluate the impact of individualized dosing on live birth rates are needed to assess whether individualized dosing should become the standard in IVF practice.

Keyphrases

pregnancy outcomes
healthcare
primary care
gestational age
preterm birth
pregnant women
metabolic syndrome
skeletal muscle
adipose tissue
insulin resistance